Daré Bioscience, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Paul A Friedman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Paul A Friedman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:MDGL / Madrigal Pharmaceuticals, Inc. Director 187.164
US:US00C4W1JQ50 / Alexion Pharmaceuticals, Inc. Director 0
US:PRLD / Prelude Therapeutics Incorporated Director 23.344
US:INCY / Incyte Corporation Director 10.514
US:CERU / Cerulean Pharma Inc. Director 18.819
US:VSTM / Verastem, Inc. Director 25.000
US:AUXL / Auxilium Pharmaceuticals Inc Director 0
US:DRTX / Durata Therapeutics Inc Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Paul A Friedman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb DARE / Daré Bioscience, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i DARE / Daré Bioscience, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

DARE / Daré Bioscience, Inc. Insider Trades
Insidersalg DARE / Daré Bioscience, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i DARE / Daré Bioscience, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

DARE / Daré Bioscience, Inc. Insider Trades
Insiderkøb MDGL / Madrigal Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i DARE / Daré Bioscience, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2018-11-20 MDGL FRIEDMAN PAUL A 4.000 117,8800 4.000 117,8800 471.520 119 143.8400 103.840 22,02
2018-11-19 MDGL FRIEDMAN PAUL A 4.000 124,0000 4.000 124,0000 496.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MDGL / Madrigal Pharmaceuticals, Inc. Insider Trades
Insidersalg MDGL / Madrigal Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i DARE / Daré Bioscience, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-06-11 MDGL FRIEDMAN PAUL A 73.526 287,4600 73.526 287,4600 21.135.784 360 91.1300 -14.435.359 -68,30

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MDGL / Madrigal Pharmaceuticals, Inc. Insider Trades
Insiderkøb PRLD / Prelude Therapeutics Incorporated – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i DARE / Daré Bioscience, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PRLD / Prelude Therapeutics Incorporated Insider Trades
Insidersalg PRLD / Prelude Therapeutics Incorporated – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i DARE / Daré Bioscience, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PRLD / Prelude Therapeutics Incorporated Insider Trades
Insiderkøb VSTM / Verastem, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i DARE / Daré Bioscience, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-12-24 VSTM FRIEDMAN PAUL A 3.000 8,3108 250 99,7296 24.932 86 1742.4 410.668 1.647,15

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VSTM / Verastem, Inc. Insider Trades
Insidersalg VSTM / Verastem, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i DARE / Daré Bioscience, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VSTM / Verastem, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Paul A Friedman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -600 187.164 -0,32 359,81 -215.886 67.343.479
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.032 187.764 -2,61 358,83 -1.805.615 67.374.699
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.434 192.796 -4,19 357,93 -3.018.786 69.007.569
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.094 201.230 -2,47 356,94 -1.818.251 71.826.996
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.244 206.324 -2,48 355,97 -1.866.710 73.445.299
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.546 211.568 -3,00 355,00 -2.323.856 75.107.486
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.768 218.114 -2,14 354,06 -1.688.137 77.224.483
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.382 222.882 -0,62 352,61 -487.309 78.590.712
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.202 224.264 -1,41 351,59 -1.125.806 78.850.011
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.303 227.466 -1,43 350,93 -1.159.113 79.824.006
2025-08-13 2025-08-12 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 43.605 230.769 23,30 9,45 412.067 2.180.767
2025-08-13 2025-08-11 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 187.164 -0,16 351,04 -105.312 65.702.256
2025-08-13 2025-08-11 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.903 187.464 -1,52 350,19 -1.016.605 65.648.224
2025-08-13 2025-08-11 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3.203 190.367 1,71 9,45 30.268 1.798.968
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.155 187.164 -2,17 374,38 -1.555.563 70.071.113
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -24.166 191.319 -11,21 373,35 -9.022.330 71.428.585
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -28.976 215.485 -11,85 372,39 -10.790.486 80.245.300
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -22.710 244.461 -8,50 371,53 -8.437.340 90.823.446
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.877 267.171 -2,86 370,44 -2.917.943 98.970.398
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.992 275.048 -2,82 369,44 -2.952.555 101.613.403
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.788 283.040 -2,34 368,34 -2.500.325 104.256.340
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.119 289.828 -2,40 367,31 -2.614.888 106.457.041
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.152 296.947 -1,05 366,22 -1.154.330 108.748.316
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.716 300.099 -0,57 365,19 -626.671 109.593.964
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.529 301.815 -1,16 364,02 -1.284.639 109.867.753
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.591 305.344 -0,84 363,08 -940.731 110.863.231
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.439 307.935 -0,47 362,29 -521.332 111.561.001
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.754 309.374 -0,56 361,13 -633.424 111.724.542
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.153 311.128 -1,00 360,27 -1.135.938 112.090.707
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -455 314.281 -0,14 359,31 -163.485 112.923.552
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.600 314.736 -0,51 358,23 -573.171 112.748.475
2025-08-13 2025-08-13 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 129.172 316.336 69,02 9,45 1.220.675 2.989.375
2025-07-22 2025-07-18 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.400 187.164 -0,74 350,03 -490.044 65.513.277
2025-07-22 2025-07-18 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.400 188.564 0,75 9,45 13.230 1.781.930
2025-07-18 2025-07-17 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -700 187.164 -0,37 351,57 -246.098 65.800.985
2025-07-18 2025-07-17 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.000 187.864 -1,05 350,10 -700.203 65.771.468
2025-07-18 2025-07-17 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.700 189.864 1,44 9,45 25.515 1.794.215
2025-07-18 2025-07-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.200 187.164 -0,64 356,62 -427.941 66.745.995
2025-07-18 2025-07-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.784 188.364 -2,98 355,61 -2.056.860 66.984.499
2025-07-18 2025-07-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.851 194.148 -3,41 354,65 -2.429.697 68.854.297
2025-07-18 2025-07-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.319 200.999 -1,14 353,82 -820.507 71.117.305
2025-07-18 2025-07-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.110 203.318 -1,03 352,67 -744.133 71.704.098
2025-07-18 2025-07-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.371 205.428 -1,14 351,38 -833.131 72.184.030
2025-07-18 2025-07-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.541 207.799 -2,60 350,17 -1.940.275 72.764.332
2025-07-18 2025-07-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 26.176 213.340 13,99 9,45 247.363 2.016.063
2025-06-24 2025-06-20 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
A - Award 715 187.164 0,38
2024-06-27 2024-06-25 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
A - Award 714 186.449 0,38
2024-04-10 2024-04-08 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.866 185.735 -2,55 248,59 -1.209.642 46.171.994
2024-04-10 2024-04-08 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.464 190.601 -1,78 247,76 -858.241 47.223.323
2024-04-10 2024-04-08 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.028 194.065 -2,53 246,96 -1.241.710 47.926.098
2024-04-10 2024-04-08 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.078 199.093 -1,03 245,71 -510.591 48.919.659
2024-04-10 2024-04-08 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.663 201.171 -2,74 244,86 -1.386.646 49.258.872
2024-04-10 2024-04-08 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.730 206.834 -1,77 244,12 -910.566 50.492.254
2024-04-10 2024-04-08 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.441 210.564 -0,68 242,95 -350.094 51.157.008
2024-04-10 2024-04-08 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 26.270 212.005 14,14 9,45 248.252 2.003.447
2024-04-05 2024-04-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -444 185.735 -0,24 245,92 -109.189 45.676.341
2024-04-05 2024-04-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.228 186.179 -2,73 245,35 -1.282.669 45.678.273
2024-04-05 2024-04-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.966 191.407 -2,03 244,22 -968.588 46.745.953
2024-04-05 2024-04-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.264 195.373 -4,53 243,20 -2.253.016 47.514.948
2024-04-05 2024-04-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.679 204.637 -3,16 242,42 -1.619.098 49.607.324
2024-04-05 2024-04-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -612 211.316 -0,29 241,15 -147.582 50.958.389
2024-04-05 2024-04-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.420 211.928 -0,67 240,10 -340.939 50.883.468
2024-04-05 2024-04-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 27.613 213.348 14,87 9,45 260.943 2.016.139
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -200 185.735 -0,11 248,42 -49.685 46.141.217
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -737 185.935 -0,39 247,14 -182.141 45.951.697
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.558 186.672 -0,83 246,13 -383.471 45.945.617
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.549 188.230 -1,34 245,14 -624.857 46.142.345
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -627 190.779 -0,33 244,31 -153.185 46.609.942
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.467 191.406 -0,76 243,00 -356.482 46.511.754
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.299 192.873 -2,67 242,25 -1.283.679 46.723.330
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.273 198.172 -3,07 241,07 -1.512.222 47.773.007
2024-04-05 2024-04-04 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 18.710 204.445 10,07 9,45 176.810 1.932.005
2024-04-05 2024-04-03 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.821 185.735 -0,97 246,31 -448.530 45.748.332
2024-04-05 2024-04-03 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18.806 187.556 -9,11 245,34 -4.613.823 46.014.576
2024-04-05 2024-04-03 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.301 206.362 -2,04 244,58 -1.051.959 50.472.988
2024-04-05 2024-04-03 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.294 210.663 -1,08 243,64 -558.921 51.326.923
2024-04-05 2024-04-03 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -185 212.957 -0,09 242,00 -44.770 51.535.594
2024-04-05 2024-04-03 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 27.407 213.142 14,76 9,45 258.996 2.014.192
2024-01-18 2023-01-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.254 20.001 -10,13 243,92 -549.796 4.878.644
2023-01-18 2023-01-16 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
A - Award 26.668 26.668
2022-02-24 2022-02-22 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 70.000 70.000
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
D - Sale to Issuer -12.840 0 -100,00
2021-06-22 2021-06-18 4 PRLD Prelude Therapeutics Inc
Director Stock Option (Right to Buy)
A - Award 23.344 23.344
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 533 12.840 4,33
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 1.962 12.307 18,97
2021-02-23 2021-02-22 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2020-09-30 2020-09-29 4 PRLD Prelude Therapeutics Inc
Series B Preferred Stock
C - Conversion -152.576 0 -100,00
2020-09-30 2020-09-29 4 PRLD Prelude Therapeutics Inc
Series A Preferred Stock
C - Conversion -295.794 0 -100,00
2020-09-30 2020-09-29 4 PRLD Prelude Therapeutics Inc
Common Stock
C - Conversion 152.576 500.098 43,90
2020-09-30 2020-09-29 4 PRLD Prelude Therapeutics Inc
Common Stock
C - Conversion 295.794 347.522 571,83
2020-09-30 2020-03-27 4 PRLD Prelude Therapeutics Inc
Series B Preferred Stock
P - Purchase 76.288 152.576 100,00
2020-09-24 3 PRLD Prelude Therapeutics Inc
Common Stock
51.728
2020-05-28 2020-05-26 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 10.514 10.514
2020-05-28 2020-05-26 4 INCY INCYTE CORP
Common Stock
A - Award 1.282 256.813 0,50
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 3.468 10.345 50,43
2020-03-05 2020-03-05 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2019-08-06 2019-08-06 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -77.934 0 -100,00
2019-08-06 2019-08-06 4 INCY INCYTE CORP
Common Stock
S - Sale -77.934 255.531 -23,37 82,20 -6.406.175 21.004.648
2019-08-06 2019-08-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 77.934 333.465 30,50 18,32 1.427.751 6.109.079
2019-08-06 2019-08-02 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -22.066 77.934 -22,07
2019-08-06 2019-08-02 4 INCY INCYTE CORP
Common Stock
S - Sale -22.066 255.531 -7,95 84,41 -1.862.591 21.569.372
2019-08-06 2019-08-02 4 INCY INCYTE CORP
Common Stock
M - Exercise 22.066 277.597 8,64 18,32 404.249 5.085.577
2019-05-17 2019-05-15 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2.726 6.877 65,67
2019-04-29 2019-04-26 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 12.472 12.472
2019-04-29 2019-04-26 4 INCY INCYTE CORP
Common Stock
A - Award 1.520 255.531 0,60
2019-03-11 2019-03-07 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2018-11-23 2018-11-20 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
P - Purchase 4.000 161.128 2,55 117,88 471.520 18.993.769
2018-11-19 2018-11-19 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
P - Purchase 4.000 157.128 2,61 124,00 496.000 19.483.872
2018-06-12 2018-06-11 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale -73.526 655.540 -10,08 287,46 -21.135.784 188.441.528
2018-05-11 2018-05-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 2.174 4.151 109,96
2018-05-03 2018-05-01 4 INCY INCYTE CORP
Non-Qualified Stock Options (right to buy)
A - Award 15.000 15.000
2018-03-05 2018-03-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2017-11-30 2017-11-29 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 1.977 1.977
2017-11-20 2017-11-16 4 INCY INCYTE CORP
Common Stock
S - Sale -28.507 269.011 -9,58 105,24 -3.000.077 28.310.718
2017-05-31 2017-05-26 4 INCY INCYTE CORP
Non-Qualified Stock Options (right to buy)
A - Award 15.000 15.000
2017-04-05 2017-04-03 4 CERU Cerulean Pharma Inc.
Common Stock
A - Award 10.273 18.819 120,21 0,73 7.499 13.738
2017-03-20 2017-03-17 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -41.693 100.000 -29,42
2017-03-20 2017-03-17 4 INCY INCYTE CORP
Common Stock
S - Sale -41.693 297.518 -12,29 148,18 -6.178.069 44.086.217
2017-03-20 2017-03-17 4 INCY INCYTE CORP
Common Stock
M - Exercise 41.693 339.211 14,01 18,32 763.816 6.214.346
2017-03-20 2017-03-16 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.849 141.693 -1,97
2017-03-20 2017-03-16 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -5.458 0 -100,00
2017-03-20 2017-03-16 4 INCY INCYTE CORP
Common Stock
S - Sale -8.307 297.518 -2,72 151,45 -1.258.095 45.059.101
2017-03-20 2017-03-16 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.849 305.825 0,94 18,32 52.194 5.602.714
2017-03-20 2017-03-16 4 INCY INCYTE CORP
Common Stock
M - Exercise 5.458 302.976 1,83 18,32 99.991 5.550.520
2017-03-06 2017-03-02 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 49.600 49.600
2017-02-27 2017-02-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -50.000 144.542 -25,70
2017-02-27 2017-02-23 4 INCY INCYTE CORP
Common Stock
S - Sale -50.000 297.518 -14,39 120,32 -6.016.000 35.797.366
2017-02-27 2017-02-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 50.000 347.518 16,81 18,32 916.000 6.366.530
2017-01-05 2017-01-03 4 CERU Cerulean Pharma Inc.
Common Stock
A - Award 4.870 8.546 132,48 0,77 3.750 6.580
2016-10-20 2016-10-03 4 CERU Cerulean Pharma Inc.
Common Stock
A - Award 3.676 3.676 1,02 3.750 3.750
2016-08-23 2016-07-22 4/A MDGL MADRIGAL PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy)
A - Award 306.256 306.256
2016-08-23 2016-07-22 4/A MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
A - Award 153.128 153.274 104.882,19
2016-07-26 2016-07-22 4 MDGL SYNTA PHARMACEUTICALS CORP
Employee Stock Option (Right to Buy)
A - Award 287.115 287.115
2016-07-26 2016-07-22 4 MDGL SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 729.066 729.066
2016-07-26 2016-07-22 4 MDGL SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 143.557 143.703 98.326,71
2016-07-26 2016-07-22 4 MDGL SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 146 146
2016-06-24 2016-06-22 4 CERU Cerulean Pharma Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2016-06-16 2016-06-14 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2016-05-31 2016-05-27 4 INCY INCYTE CORP
Non-Qualified Stock Options (right to buy)
A - Award 15.000 15.000
2015-11-19 2015-11-18 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -125.000 0 -100,00
2015-11-19 2015-11-18 4 INCY INCYTE CORP
Common Stock
S - Sale -38.868 297.518 -11,55 115,12 -4.474.484 34.250.272
2015-11-19 2015-11-18 4 INCY INCYTE CORP
Common Stock
S - Sale -86.132 336.386 -20,39 115,42 -9.941.355 38.825.672
2015-11-19 2015-11-18 4 INCY INCYTE CORP
Common Stock
M - Exercise 125.000 422.518 42,01 17,79 2.223.750 7.516.595
2015-11-19 2015-11-17 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -94.379 125.000 -43,02
2015-11-19 2015-11-17 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -5.621 0 -100,00
2015-11-19 2015-11-17 4 INCY INCYTE CORP
Common Stock
S - Sale -50.000 297.518 -14,39 111,37 -5.568.500 33.134.580
2015-11-19 2015-11-17 4 INCY INCYTE CORP
Common Stock
S - Sale -42.948 347.518 -11,00 112,53 -4.832.938 39.106.201
2015-11-19 2015-11-17 4 INCY INCYTE CORP
Common Stock
S - Sale -7.052 390.466 -1,77 112,71 -794.831 44.009.423
2015-11-19 2015-11-17 4 INCY INCYTE CORP
Common Stock
M - Exercise 100.000 397.518 33,61 17,79 1.779.000 7.071.845
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 20.000 20.000
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 1.136 6.817 20,00
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 5.681 5.681
2015-06-30 2015-06-26 4 CERU Cerulean Pharma Inc.
Stock Option (Right to Buy)
A - Award 11.000 11.000
2015-06-30 2015-06-26 4 CERU Cerulean Pharma Inc.
Stock Option (Right to Buy)
A - Award 8.214 8.214
2015-06-16 2015-06-12 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 19.495 19.495
2015-05-28 2015-05-27 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -69.132 0 -100,00
2015-05-28 2015-05-27 4 INCY INCYTE CORP
Common Stock
S - Sale -16.436 297.518 -5,24 107,19 -1.761.775 31.890.954
2015-05-28 2015-05-27 4 INCY INCYTE CORP
Common Stock
S - Sale -52.696 313.954 -14,37 107,66 -5.673.251 33.800.288
2015-05-28 2015-05-27 4 INCY INCYTE CORP
Common Stock
M - Exercise 69.132 366.650 23,24 14,72 1.017.623 5.397.088
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -127.619 69.132 -64,86
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
S - Sale -22.642 297.518 -7,07 107,15 -2.426.090 31.879.054
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
S - Sale -50.000 320.160 -13,51 107,00 -5.350.000 34.257.120
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
S - Sale -50.000 320.160 -13,51 107,00 -5.350.000 34.257.120
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
S - Sale -2.358 370.160 -0,63 107,36 -253.155 39.740.378
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
S - Sale -2.619 422.518 -0,62 107,83 -282.407 45.560.116
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
M - Exercise 127.619 425.137 42,89 14,72 1.878.552 6.258.017
2015-05-27 2015-05-22 4 INCY INCYTE CORP
Non-Qualified Stock Options (right to buy)
A - Award 15.000 15.000
2015-05-26 2015-05-22 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -79.592 196.751 -28,80
2015-05-26 2015-05-22 4 INCY INCYTE CORP
Common Stock
S - Sale -25.000 297.518 -7,75 107,88 -2.697.000 32.096.242
2015-05-26 2015-05-22 4 INCY INCYTE CORP
Common Stock
S - Sale -25.000 322.518 -7,19 107,75 -2.693.750 34.751.314
2015-05-26 2015-05-22 4 INCY INCYTE CORP
Common Stock
S - Sale -15.200 347.518 -4,19 108,50 -1.649.200 37.705.703
2015-05-26 2015-05-22 4 INCY INCYTE CORP
Common Stock
S - Sale -14.392 362.718 -3,82 108,34 -1.559.229 39.296.868
2015-05-26 2015-05-22 4 INCY INCYTE CORP
Common Stock
M - Exercise 79.592 377.110 26,75 14,72 1.171.594 5.551.059
2015-05-26 2015-05-21 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -13.846 276.343 -4,77
2015-05-26 2015-05-21 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -8.805 0 -100,00
2015-05-26 2015-05-21 4 INCY INCYTE CORP
Common Stock
S - Sale -14.388 297.518 -4,61 108,92 -1.567.141 32.405.661
2015-05-26 2015-05-21 4 INCY INCYTE CORP
Common Stock
S - Sale -8.263 311.906 -2,58 108,75 -898.601 33.919.778
2015-05-26 2015-05-21 4 INCY INCYTE CORP
Common Stock
M - Exercise 13.846 320.169 4,52 14,72 203.813 4.712.888
2015-05-26 2015-05-21 4 INCY INCYTE CORP
Common Stock
M - Exercise 8.805 306.323 2,96 14,72 129.610 4.509.075
2015-02-18 2015-02-13 4 INCY INCYTE CORP
Common Stock
S - Sale -60.000 297.518 -16,78 74,39 -4.463.400 22.132.364
2015-02-18 2015-02-13 4 INCY INCYTE CORP
Common Stock
S - Sale -60.000 357.518 -14,37 74,25 -4.455.000 26.545.712
2015-01-30 2015-01-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
Nonqualified Stock Option (Right to Buy)
J - Other -5.000 0 -100,00 36,53 -182.650
2015-01-30 2015-01-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
Nonqualified Stock Option (Right to Buy)
J - Other -5.000 0 -100,00 36,53 -182.650
2015-01-30 2015-01-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
Nonqualified Stock Option (Right to Buy)
J - Other -15.000 0 -100,00 36,53 -547.950
2015-01-30 2015-01-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
J - Other -5.000 0 -100,00 36,53 -182.650
2015-01-30 2015-01-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
J - Other -5.361 5.000 -51,74
2014-12-29 2014-12-24 4 VSTM Verastem, Inc.
Common Stock
P - Purchase 3.000 3.000 8,31 24.932 24.932
2014-12-08 2014-12-05 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
S - Sale -9.689 10.361 -48,32 33,85 -327.953 350.699
2014-12-08 2014-12-04 4 AUXL AUXILIUM PHARMACEUTICALS INC
Nonqualified Stock Option (Right to Buy)
M - Exercise -5.000 0 -100,00
2014-12-08 2014-12-04 4 AUXL AUXILIUM PHARMACEUTICALS INC
Nonqualified Stock Option (Right to Buy)
M - Exercise -15.000 0 -100,00
2014-12-08 2014-12-04 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
S - Sale -20.000 20.050 -49,94 33,67 -673.452 675.136
2014-12-08 2014-12-04 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
M - Exercise 5.000 40.050 14,27 14,37 71.850 575.518
2014-12-08 2014-12-04 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
M - Exercise 15.000 35.050 74,81 19,78 296.700 693.289
2014-11-19 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
D - Sale to Issuer -8.575 0 -100,00
2014-11-19 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
D - Sale to Issuer -11.145 0 -100,00
2014-11-07 2014-11-06 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -29.166 0 -100,00
2014-11-07 2014-11-06 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -156.487 0 -100,00
2014-11-07 2014-11-06 4 INCY INCYTE CORP
Common Stock
S - Sale -185.653 417.518 -30,78 67,87 -12.600.269 28.336.947
2014-11-07 2014-11-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 29.166 603.171 5,08 13,34 389.074 8.046.301
2014-11-07 2014-11-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 156.487 574.005 37,48 9,41 1.472.543 5.401.387
2014-10-31 2014-10-29 4 CERU Cerulean Pharma Inc.
Stock Option (right to buy)
A - Award 100.000 113.786 725,37
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 10.000 10.000
2014-05-28 2014-05-28 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
2014-05-23 2014-05-21 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
A - Award 8.575 19.720 76,94
2014-05-22 2014-05-21 4 AUXL AUXILIUM PHARMACEUTICALS INC
Nonqualified Stock Option (Right to Buy)
A - Award 5.000 5.000
2014-05-22 2014-05-21 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 5.000 20.054 33,21
2014-05-13 2014-05-12 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 50.000 50.000
2014-03-05 2014-03-03 4 SNTA SYNTA PHARMACEUTICALS CORP
Non-Employee Director Stock Option (Right to Buy)
A - Award 20.000 20.000
2014-03-05 3 SNTA SYNTA PHARMACEUTICALS CORP
No securities are beneficially owned.
0
2014-02-21 2014-02-20 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -33.354 0 -100,00
2014-02-21 2014-02-20 4 INCY INCYTE CORP
Common Stock
S - Sale -33.354 417.518 -7,40 63,51 -2.118.313 26.516.568
2014-02-21 2014-02-20 4 INCY INCYTE CORP
Common Stock
M - Exercise 33.354 450.872 7,99 3,11 103.731 1.402.212
2014-02-19 2014-02-19 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -40.919 33.354 -55,09
2014-02-19 2014-02-19 4 INCY INCYTE CORP
Common Stock
S - Sale -40.919 417.518 -8,93 62,66 -2.563.985 26.161.678
2014-02-19 2014-02-19 4 INCY INCYTE CORP
Common Stock
M - Exercise 40.919 458.437 9,80 3,11 127.258 1.425.739
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -120.171 74.273 -61,80
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -185.753 0 -100,00
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -193.520 0 -100,00
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -39.166 0 -100,00
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -181.426 0 -100,00
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Common Stock
S - Sale -720.036 417.518 -63,30 65,82 -47.392.770 27.481.035
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Common Stock
M - Exercise 120.171 1.137.554 11,81 3,11 373.732 3.537.793
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Common Stock
M - Exercise 185.753 1.017.383 22,34 5,46 1.014.211 5.554.911
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Common Stock
M - Exercise 193.520 831.630 30,33 8,99 1.739.745 7.476.354
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Common Stock
M - Exercise 39.166 638.110 6,54 8,99 352.102 5.736.609
2014-02-19 2014-02-18 4 INCY INCYTE CORP
Common Stock
M - Exercise 181.426 598.944 43,45 11,98 2.173.483 7.175.349
2014-02-19 2014-02-14 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -10.227 181.426 -5,34
2014-02-19 2014-02-14 4 INCY INCYTE CORP
Common Stock
S - Sale -10.227 417.518 -2,39 65,52 -670.073 27.355.779
2014-02-19 2014-02-14 4 INCY INCYTE CORP
Common Stock
M - Exercise 10.227 427.745 2,45 11,98 122.519 5.124.385
2014-01-23 2014-01-21 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 7.500 7.500
2014-01-14 2014-01-10 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
J - Other 2.454 15.054 19,48
2014-01-14 2014-01-10 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
J - Other -1.227 0 -100,00
2014-01-14 2014-01-10 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
J - Other -1.227 0 -100,00
2014-01-02 2013-12-31 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 361 12.600 2,95 20,73 7.484 261.198
2013-12-20 2013-12-20 4 INCY INCYTE CORP
Common Stock
F - Taxes -24.350 417.518 -5,51 50,11 -1.220.178 20.921.827
2013-10-01 2013-09-30 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 411 12.239 3,47 18,20 7.480 222.750
2013-09-12 2013-09-10 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -189.105 0 -100,00
2013-09-12 2013-09-10 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -43.125 0 -100,00
2013-09-12 2013-09-10 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -144.559 0 -100,00
2013-09-12 2013-09-10 4 INCY INCYTE CORP
Common Stock
S - Sale -376.789 391.868 -49,02 37,32 -14.061.765 14.624.514
2013-09-12 2013-09-10 4 INCY INCYTE CORP
Common Stock
M - Exercise 189.105 768.657 32,63 7,09 1.340.754 5.449.778
2013-09-12 2013-09-10 4 INCY INCYTE CORP
Common Stock
M - Exercise 43.125 579.552 8,04 8,64 372.600 5.007.329
2013-09-12 2013-09-10 4 INCY INCYTE CORP
Common Stock
M - Exercise 144.559 536.427 36,89 8,64 1.248.990 4.634.729
2013-07-02 2013-06-28 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 450 11.828 3,96 16,63 7.484 196.700
2013-05-20 2013-05-16 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
A - Award 11.145 11.145
2013-05-07 2013-05-06 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -13.513 0 -100,00
2013-05-07 2013-05-06 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -834 0 -100,00
2013-05-07 2013-05-06 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -1.006 8.805 -10,25
2013-05-07 2013-05-06 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -8.347 0 -100,00
2013-05-07 2013-05-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 13.513 391.868 3,57 9,41 127.157 3.687.478
2013-05-07 2013-05-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 834 378.355 0,22 13,34 11.126 5.047.256
2013-05-07 2013-05-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 1.006 377.521 0,27 14,72 14.808 5.557.109
2013-05-07 2013-05-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 8.347 376.515 2,27 11,98 99.997 4.510.650
2013-05-03 2013-05-01 4 AUXL AUXILIUM PHARMACEUTICALS INC
Nonqualified Stock Option (Right to Buy)
A - Award 5.000 5.000
2013-05-03 2013-05-01 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 5.000 11.378 78,39
2013-04-02 2013-03-28 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 433 6.378 7,28 17,29 7.487 110.276
2013-02-12 2013-02-09 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 194.542 194.542
2013-02-12 2013-02-09 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 5.458 5.458
2013-01-03 2012-12-31 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
G - Gift -1.227 5.945 -17,11
2013-01-03 2012-12-31 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
G - Gift -1.227 5.945 -17,11
2013-01-03 2012-12-31 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 404 8.399 5,05 18,54 7.490 155.712
2012-12-20 2012-12-20 4 INCY INCYTE CORP
Common Stock
F - Taxes -16.725 318.168 -4,99 16,15 -270.109 5.138.413
2012-10-02 2012-09-28 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 306 7.995 3,98 24,46 7.485 195.558
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -1.875 0 -100,00
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -10.441 0 -100,00
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -834 0 -100,00
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -6.480 0 -100,00
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -5.556 0 -100,00
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Common Stock
M - Exercise 1.875 334.893 0,56 8,64 16.200 2.893.476
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Common Stock
M - Exercise 10.441 333.018 3,24 8,64 90.210 2.877.276
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Common Stock
M - Exercise 834 322.577 0,26 8,99 7.498 2.899.967
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Common Stock
M - Exercise 6.480 321.743 2,06 8,99 58.255 2.892.470
2012-07-12 2012-07-10 4 INCY INCYTE CORP
Common Stock
M - Exercise 5.556 315.263 1,79 3,11 17.279 980.468
2012-07-03 2012-06-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 231 7.689 3,10 26,89 6.212 206.757
2012-06-22 2012-06-21 4 AUXL AUXILIUM PHARMACEUTICALS INC
Nonqualified Stock Option (Right to Buy)
A - Award 5.000 5.000
2012-06-22 2012-06-21 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 5.000 7.454 203,75
2012-05-08 2012-05-07 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -225.000 0 -100,00
2012-05-08 2012-05-07 4 INCY INCYTE CORP
Common Stock
S - Sale -225.000 309.707 -42,08 22,56 -5.076.000 6.986.990
2012-05-08 2012-05-07 4 INCY INCYTE CORP
Common Stock
M - Exercise 225.000 534.707 72,65 5,97 1.343.250 3.192.201
2012-04-03 2012-03-30 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 336 2.454 15,86 18,57 6.240 45.571
2012-01-23 2012-01-19 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 219.379 219.379
2012-01-23 2012-01-19 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 5.621 5.621
2012-01-06 2012-01-05 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 236 2.118 12,54 19,05 4.496 40.348
2012-01-04 2011-12-30 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
A - Award 312 1.882 19,87 19,93 6.218 37.508
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)